Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Dual Therapy Combined With Probiotics for H. Pylori Rescue
NCT06292546Completed
- Sponsor
- Zhongshan Hospital (Xiamen), Fudan University
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of bacillus subtilis in Helicobacter pylori infection (4 arms), sponsored by Zhongshan Hospital (Xiamen), Fudan University. Primary endpoint: Gut Microbiota at Day 104. Started Jan 2024; status: completed.
02
Drugs
bacillus subtilis
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06292546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06292546.